Pregabalin + NortriptylineThird Party Manufacturing in India

Pregabalin and Nortriptyline combines a gabapentinoid anticonvulsant with a tricyclic antidepressant to provide multimodal analgesia for neuropathic pain. Pregabalin binds to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels in the central nervous system, reducing calcium influx and thereby decreasing the release of excitatory neurotransmitters including glutamate, noradrenaline, and substance P that mediate pain signaling. Nortriptyline, a secondary amine tricyclic antidepressant, works primarily by inhibiting the reuptake of serotonin and norepinephrine at the presynaptic neuronal membrane, increasing their concentrations in the synaptic cleft. This enhances descending inhibitory pain pathways from the brainstem to the spinal cord. Nortriptyline also blocks N-type calcium channels and voltage-gated sodium channels, providing additional analgesic effects independent of its monoamine reuptake inhibition. Additionally, nortriptyline exhibits antagonist activity at histamine H1, muscarinic, and alpha-adrenergic receptors, contributing to its sedative and analgesic profile. The combination of pregabalin and nortriptyline targets both the peripheral and central mechanisms of neuropathic pain through complementary pathways. Pregabalin reduces excitatory neurotransmitter release at the spinal level, while nortriptyline potentiates descending inhibitory pathways and provides direct sodium and calcium channel blockade for enhanced pain relief.

Therapeutic Uses

Pregabalin + Nortriptyline is prescribed for the treatment of:

• Chronic Neuropathic Pain: The combination is particularly effective for mixed nociceptive and neuropathic pain conditions where monotherapy with either agent alone proves insufficient.
• Diabetic Peripheral Neuropathy: This dual-mechanism combination addresses both the burning pain and paresthesias characteristic of diabetic nerve damage.
• Postherpetic Neuralgia: Persistent pain following herpes zoster infection responds well to the combination of gabapentinoid and tricyclic antidepressant therapy.
• Fibromyalgia: The combination provides pain relief and improves sleep quality, addressing two core symptoms of fibromyalgia syndrome.
• Chronic Low Back Pain with Radiculopathy: Neuropathic components of chronic back pain benefit from the multimodal analgesic approach.
• Migraine Prophylaxis: Nortriptyline's established role in migraine prevention combined with pregabalin's analgesic effects offers a useful option for chronic migraine with neuropathic features.

Why Manufacturers Choose Pregabalin + Nortriptyline

The pregabalin and nortriptyline fixed-dose combination is a relatively newer entrant in the Indian neuropathic pain market, offering manufacturers a differentiated product in a crowded segment. The combination addresses the clinical reality that many neuropathic pain patients require multimodal therapy, providing a single-tablet solution that improves compliance compared to taking two separate medications. This product is particularly popular among PCD franchise companies targeting neurologists, diabetologists, and pain management specialists. The 75mg+10mg strength represents the most commonly prescribed dose, balancing efficacy with tolerability. Manufacturers with WHO-GMP certification and expertise in fixed-dose combination manufacturing are well-positioned to capture market share in this growing segment. The competitive pricing advantage of Indian manufacturers further supports strong export potential to emerging markets in Africa, Southeast Asia, and the Middle East where neuropathic pain treatment guidelines increasingly recommend combination therapy.

This makes Pregabalin + Nortriptyline one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.